Ohr Pharmaceutical, Inc.

Company Listings from SPi: Ohr Pharmaceutical, Inc.

You are here: Home >> SPi Company Listings >> Ohr Pharmaceutical, Inc.

 

Ohr Pharmaceutical, Inc.

Website:
http://

Search for other references to "pharmaceutical" on SPi News

Latest Ohr Pharmaceutical, Inc. News

Ohr Pharmaceutical, Inc. Announces Stockholder Approval of Merger Agreement with NeuBase Therapeutics, Inc. NEW YORK, July 10, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr”) (Nasdaq: OHRP) today announced that all proposals related to its proposed merger with NeuBase The...... 18:03 GMT Wednesday 10th July 2019

Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 NEW YORK, July 03, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) (the “Company” or “Ohr”) reiterated the unanimous recommendation of its Board of Direc...... 15:00 GMT Wednesday 3rd July 2019

Ohr Pharmaceutical Reports Financial Results for the Fiscal Second Quarter of 2019 NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) (the “Company” or “Ohr”) today reported financial results for the three and six month p...... 21:01 GMT Wednesday 15th May 2019

Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it received notice from The Nasdaq Stock Market LLC indicating that the C...... 15:45 GMT Thursday 21st February 2019

Ohr Pharmaceutical Reports Financial Results for the Fiscal First Quarter of 2019 NEW YORK, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) (the “Company” or “Ohr”) today reported financial results for the three months ended D...... 21:05 GMT Thursday 14th February 2019

Ohr Pharmaceutical Announces Reverse Stock Split to be Effective February 4, 2019 NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (Nasdaq: OHRP) announced today that its board of directors has determined to...... 21:30 GMT Wednesday 23rd January 2019

Ohr Pharmaceutical, Inc. Announces Merger Agreement with NeuBase Therapeutics, Inc. NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr”) (Nasdaq: OHRP) announced today that it has entered into a definitive merger agreement with NeuBa...... 11:30 GMT Thursday 3rd January 2019

Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial Results NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financi...... 21:05 GMT Tuesday 14th August 2018

Ohr Pharmaceutical Reports Fiscal Second Quarter 2018 Financial Results NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financial...... 21:05 GMT Tuesday 15th May 2018

Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financia...... 21:05 GMT Wednesday 14th February 2018

Buy Ohr Pharmaceutical, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us